Stada benefits from wave of illnesses and strong Russian business
BAD VILBEL (dpa-AFX) - Strong growth in over-the-counter medicines and strong business in Russia are driving drug producer Stada. Last year, sales rose 17 percent to just under 3.8 billion euros, the company announced…